Harvard Pilgrim Health Care Home
  Learn more.
  Sign up for HPHConnect.
Medical Management
For Your Patient
News Center
Network Matters
Newsletter Archives
Newsletter Registration
Office Support
Provider Manual
Medicare Advantage
Research & Teaching
Resources & Links
Print    Text Size

Network Matters
News and Information for the
Harvard Pilgrim Health Care Network

September 2013

Synagis for the Upcoming RSV Season 

With respiratory syncytial virus (RSV) season nearly approaching, Harvard Pilgrim would like to remind providers of our policy regarding Synagis (palivizumab), an injection of antibodies used to protect high-risk infants from severe RSV disease. Harvard Pilgrim will be using the same prior authorization and distribution process for Synagis (palivizumab) during the 2013–2014 RSV season as we did last season.

Synagis requires prior authorization and should be reserved for children with a history of pre-term birth, chronic lung disease, or congenital heart disease. Typically, the first dose is administered at the beginning of November and the last dose at the beginning of March, in order to provide protection through April.

Clinicians may order Synagis for their Harvard Pilgrim patients by faxing the Synagis Medication Request Form to ICORE Healthcare at (866) 554-2673. If the prior authorization criteria are met, ICORE will ship approval orders directly to clinicians’ offices and will bill Harvard Pilgrim. For updated information, please see the Pharmacy Program page, or call Clinical Pharmacy Services at
(617) 509-1786.

Email this article to a colleague   

Receive Network Matters by e-mail

Network Matters Archives

Download printer-friendly version


Participate in ICD-10 Validation Self-Testing

ChoiceNet and Hospital Prefer 2014 Tiers

ElevateHealth: A New HMO Product for NH


More Dialysis Facilities Available

Synagis for the Upcoming RSV Season

Choosing Wisely: Educating Consumers About Medical Tests

Recognizing Post-traumatic Stress Disorder in the Primary Care Setting


Reminder: HPHConnect New User Accounts Changes


Eric H. Schultz,
President and Chief Executive Officer

Richard Weisblatt PhD,
Senior Vice President, Provider Network

Annmarie Dadoly,

Kristin Edmonston,
Production Coordinator